Anne Wojcicki’s nonprofit, TTAM Research Institute, won 23andMe’s court-supervised bankruptcy auction with a $305 million cash bid, and the sale closed on July 14, 2025. “Bought back the company” is headline shorthand: TTAM acquired specified assets from the bankrupt company, not its publicly traded shares. For customers, the sale documents and current consent materials describe privacy commitments and choices, but they do not make genetic data risk-free.
How TTAM won the auction
23andMe Holding Co. filed for Chapter 11 bankruptcy protection on March 23, 2025, in the U.S. Bankruptcy Court for the Eastern District of Missouri, and pursued a court-supervised sale of substantially all its assets. (SEC filing)
At the first auction, the company selected Regeneron as the successful bidder and TTAM as the backup. Regeneron’s bid was $256 million in cash, plus specified liabilities. TTAM later offered $305 million in cash. After a further bidding round, the company selected TTAM as the winner on June 13, 2025; Regeneron became the backup bidder, and its agreement was terminated. These were bids under different agreements, so the headline figures alone do not establish that each bidder would have assumed identical liabilities. (SEC filing)
| Bidder | Stage and amount | Outcome |
|---|---|---|
| Regeneron | Initial successful bid: $256 million in cash, plus specified liabilities, according to 23andMe’s 2025 SEC filing. | Later became the backup bidder after TTAM won the final round. |
| TTAM Research Institute | Later winning bid: $305 million in cash, in addition to specified liabilities and cure payments under the agreement, according to 23andMe’s 2025 SEC filing. | Selected as the winner on June 13, 2025. |
What “buys back the company” means
TTAM Research Institute was a California nonprofit public benefit corporation affiliated with and led by 23andMe co-founder and former CEO Anne Wojcicki. The transaction was an acquisition of substantially all specified assets from the debtor—not a purchase of the former public company’s shares. (SEC filing)
#1 Best Overall
- MAP YOUR ORIGINS ACROSS 5,000+ REGIONS: Ancestry Composition breaks down your ethnicity across 5,000+ geographic regions worldwide, the most detailed ancestry breakdown of any consumer DNA service. Ancestry Timeline estimates how many generations ago your most recent ancestor from each population lived.
- FIND LIVING RELATIVES: Opt in to DNA Relatives to see up to 1,500 people in the 23andMe database who share DNA with you, from close family to distant cousins, and message them directly. Your Family Tree builds itself automatically based on your DNA.
- DISCOVER WHAT MAKES YOU UNIQUE: See how your DNA may influence physical features, sensory preferences, and habits across 30+ traits, including cilantro taste aversion to hair texture to deep sleep.
- TRACE ANCIENT MIGRATIONS: Maternal and Paternal Haplogroup reports follow your ancestors' migration paths across continents over thousands of years (paternal haplogroup requires a Y chromosome). Find out how much of your ancestry can be traced back to the Neanderthals.
- PRIVATE BY DESIGN: Your DNA data is encrypted, protected, and always under your control. Enhanced security measures are implemented to keep your information safe. Subject to 23andMe’s Terms of Service and Privacy Statement at 23andMe online.
The principal businesses in the asset sale were the Personal Genome Service, which included consumer DNA testing, and Research Services. Lemonaid Health’s telehealth business was handled separately in the transaction structure: the filing identifies it as excluded from the core asset sale and describes a separate $2.5 million stalking-horse arrangement. It would be inaccurate to describe all Lemonaid operations as simply transferred with the main assets. (SEC filing)
When the sale closed
The bankruptcy court approved the TTAM transaction on June 27, 2025, and it closed on July 14, 2025. 23andMe announced completion after the court approval. (23andMe announcement)
Rank #2
- REVIEW IMPORTANT TEST INFO: There is a lot to consider with genetic testing. Before purchasing, review important information about Genetic Health Risk*, Carrier Status*, and Pharmacogenetics** reports at 23andme. org/test-info and 23andme. org/test-info/pharmacogenetics. A portion of your purchase may be eligible for FSA/HSA reimbursement***.
- UNDERSTAND YOUR GENETIC HEALTH: Receive 160+ personalized genetic reports, including 50+ Conditions* and wellness reports. Get insights into heart health, metabolic health, mental health, and more. You choose whether to view certain reports.
- TRACK HEALTH GOALS: Health Tracks(SM) show how everyday choices may shape your health over time. Opt in to the Family Health History Tree to input and track information to share with your healthcare provider.
- PLAN AHEAD WITH 45+ CARRIER STATUS REPORTS*: Find out whether you carry a genetic variant for inherited conditions across categories like blood, lung, and hearing health, information you can bring to family planning conversations with your healthcare provider.
- LEARN HOW YOUR BODY MAY RESPOND: FDA-authorized pharmacogenetics reports show how your DNA may impact the way your body processes certain medications**, including some used in heart health and mental health care. Talk to your healthcare provider before making any medication changes.
At the time of approval, Mark Jensen, chair of the board and a member of its special committee, said the transaction would help ensure that 23andMe’s founding mission “lives on globally.” That was the company’s stated intention for the sale, not an independent assessment of its effects.
What the sale says about customer privacy
TTAM said it would follow 23andMe’s existing privacy policies and preserve customer choice and transparency, including a way to change research-participation decisions. State officials said the final sale conditions added consumer and security protections, including deletion rights and requirements for future data transfers. These are commitments and legal conditions—not a guarantee that data cannot be exposed or misused. (Missouri Attorney General)
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Rank #3
- REVIEW IMPORTANT TEST INFO: There is a lot to consider with genetic testing. Before purchasing, review important information about Genetic Health Risk* and Carrier Status* reports at 23andme. org/test-info. A portion of your purchase may be eligible for FSA/HSA reimbursement***.
- UNDERSTAND YOUR GENETIC HEALTH: Get 10+ Condition reports* that show whether you have genetic variants associated with a higher risk of certain conditions. Includes FDA-authorized reports, and you choose whether to view certain reports.
- PLAN AHEAD WITH 45+ CARRIER STATUS REPORTS*: Discover if you carry a genetic variant for inherited conditions across categories like blood, lung, and hearing health, information you can bring to family planning conversations with your healthcare provider.
- OPTIMIZE YOUR DAILY WELLNESS: See how your genes may influence lifestyle factors like deep sleep, lactose intolerance, genetic weight, and muscle composition.
- MAP YOUR ORIGINS ACROSS 5,000+ REGIONS: Explore your Ancestry Composition, trace maternal and paternal haplogroups (paternal requires a Y chromosome), and dig into your Neanderthal Ancestry. Opt in to find up to 1,500 DNA Relatives, and your Family Tree builds itself automatically.
The question “I’m a 23andMe customer. Is my genetic data safe?” cannot be answered with one blanket assurance. Your choices depend in part on account settings and consent decisions, and data security always carries some risk. 23andMe Research Institute’s current consent page describes separate options for broad research participation, sharing individual-level data with qualified collaborators, and storing or re-analyzing a physical DNA sample for future research. The company says research participation is optional, choices can be changed or withdrawn in account settings, and research is subject to independent institutional review board (IRB) review. (23andMe Research Institute consent information)
The 2023 breach remains relevant to evaluating those assurances. In a 2026 update on a multistate settlement, the Maryland Attorney General said the breach affected 6.9 million consumers and described settlement provisions requiring security measures, advisory oversight, privacy-law commitments, and consumer deletion rights. This is the state’s account of its investigation and settlement. (Maryland Attorney General)
Rank #4
- Discover your ancestry and find relatives you never knew existed on both your maternal and paternal sides.
- Get a detailed ethnicity breakdown with the most comprehensive list of ethnicities in the industry: 42 regions, including 7 East Asian regions.
- Simple DNA test kit with a cheek swab - takes only 2 minutes to complete.
- Huge global database enables you to get worldwide DNA Matches.
- Affordable price - includes access to test results. Uses the highest technological standards.
What the nonprofit has done since the acquisition
On May 20, 2026, 23andMe Research Institute announced a partnership with HealthEx to connect member-authorized medical records. The announcement described Health Summary as in development and available to customers participating in a beta program—not as a finished service generally available to all customers. The institute reported more than 30,000 beta participants, more than 11 million consented research participants, and more than 4 billion phenotypic data points. Those figures are the institute’s own reported numbers, not independent audit results. (23andMe Research Institute announcement)
Quick Recap
Best Value
- TOP-SELLING CONSUMER DNA TEST: From your origins in over 3,600 places around the world to the most connections to living relatives, no other DNA test kit delivers an experience as unique and interactive as AncestryDNA.
- YOUR DATA, YOUR CONTROL: We give you full control over your genetic information. You decide what to share, and with whom.
- A FEW SIMPLE STEPS: Simply activate your DNA kit online and return your saliva sample in the prepaid package to our state-of-the-art lab. Your results will be available online in roughly six weeks.
- ORIGINS AND INHERITANCE: AncestryDNA provides more precise ancestral origins with greater geographic detail. Our innovative SideView technology takes your results even further by showing your origins and matches by parental side. *Some DNA features require an Ancestry subscription.
- BUILD YOUR FAMILY TREE: Combine what you learn from your DNA results with an Ancestry subscription and gain access to millions of family trees and the world's largest collection of online family history records. *Access to record collections varies depending on subscription level.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
